Publications — Radcliffe Department of Medicine

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial

Muir KW. et al, (2024), The Lancet Neurology, 23, 1087 - 1096

Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial.

Werring DJ. et al, (2024), Lancet

Transient Ischaemic attack Emergency Referral (TIER): randomised feasibility trial results.

Watkins A. et al, (2024), Emerg Med J

A lifetime economic model of mortality and secondary care use for patients discharged from hospital following acute stroke.

McMeekin PJ. et al, (2024), Int J Stroke

Accessing mechanical thrombectomy treatment for stroke in England, Wales and Northern Ireland: the importance of the emergency pathway.

Price C. et al, (2024), Emerg Med J

Extending mechanical thrombectomy service provision to 24/7: a break-even analysis.

Balami JS. et al, (2024), BMC Health Serv Res, 24

Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trial.

Sheppard JP. et al, (2024), Lancet Healthy Longev

Intensive Ambulance-Delivered Blood-Pressure Reduction in Hyperacute Stroke.

Li G. et al, (2024), N Engl J Med, 390, 1862 - 1872

Statistical Analysis Plan for the INTEnsive Ambulance-Delivered Blood Pressure Reduction in Hyper-ACute Stroke Trial.

Billot L. et al, (2024), Cerebrovasc Dis, 1 - 4

Healthcare professional views about a prehospital redirection pathway for stroke thrombectomy: a multiphase deductive qualitative study.

Day J. et al, (2024), Emerg Med J

Expert opinions from the 2024 closed door round table discussion on improving stroke prehospital care globally.

Liu R. et al, (2024), CNS Neurosci Ther, 30

The impact of large core and late treatment trials: An update on the modelled annual thrombectomy eligibility of UK stroke patients.

McMeekin P. et al, (2024), European stroke journal

Enhancement of STroke REhabilitation with Levodopa (ESTREL): Rationale and design of a randomized placebo-controlled, double blind superiority trial

Zietz A. et al, (2024), European Stroke Journal

Update on the INTEnsive ambulance-delivered blood pressure Reduction in hyper-ACute stroke Trial (INTERACT4): progress and baseline features in 2053 participants.

Chen C. et al, (2023), Trials, 24

Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization-Lancet Neurology Commission.

Feigin VL. et al, (2023), The Lancet. Neurology, 22, 1160 - 1206

Optimizing lipid management-impact of the COVID 19 pandemic upon cardiovascular risk in England.

Newton JL. et al, (2023), Br Med Bull, 146, 19 - 26

Is bureaucracy being busted in research ethics and governance for health services research in the UK? Experiences and perspectives reported by stakeholders through an online survey.

Snooks H. et al, (2023), BMC Public Health, 23

Research letter: An updated survey of intra-arterial mechanical thrombectomy service provision in England.

White PM. et al, (2023), Eur Stroke J, 8, 598 - 599

Results of an international survey on the status of prehospital care.

Rudd AG. et al, (2023), Int J Stroke

Informed consent in randomised controlled trials: further development and evaluation of the participatory and informed consent (PIC) measure.

Wade J. et al, (2023), Trials, 24

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?